McLoughlin Margaret 4
4 · Cortexyme, Inc. · Filed Oct 12, 2021
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
McLoughlin Margaret
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-10-08−1,000→ 84,911 totalExercise: $17.00Exp: 2029-05-07→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2021-10-08$17.00/sh+1,000$17,000→ 1,000 total - Sale
Common Stock
2021-10-08$88.93/sh−1,000$88,930→ 0 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2021.
- [F2]The option vested as to 1/3rd of the shares on May 8, 2020, with the remaining 2/3rd of shares vesting in equal monthly installments beginning on June 8, 2020 and ending on May 8, 2022.